Search:







Total 464 results.
Sort by Relevant
International Markets for Specialty Peripheral Vascular Products (2015)
85 Pages | 41 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The international market for atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices was valued at $733 million during 2013. This new report from Life Science Intelligence explores the market for these devices in Europe, Asia-Pacific and the rest of the world and analyzes key factors influencing the international market, such as how clinical studies in support of product approvals in the U.S. could affect uptake and utilization in Europe; the e...[Read More]




U.S. Markets for Specialty Peripheral Vascular Products (2015)
72 Pages | 31 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices accounted for $836 million in U.S. sales during 2013. As discussed in Life Science Intelligence's new report, strong growth is expected in the U.S. market in coming years due to clinical efforts to improve the effectiveness of interventional methods for treating peripheral artery disease (PAD); attempts to refine techniques; and the impact of new products such as drug-coated balloons (DCBs...[Read More]




U.S. Markets for Critical Care Patient Management Products (2014)
179 Pages | 50 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Critical care in the U.S. is expanding rapidly, particularly as hospital lengths of stay decrease, and the intensity of care and acuity of patients admitted to hospitals increase. Hospitals are evolving into critical care centers to which only the most seriously ill patients are admitted. Virtually every hospital unit has a significant percentage of patients benefiting from advanced technologies and equipment necessary for sustaining life, or for rapidly identifying severe clinical conditio...[Read More]




U.S. Markets for Respiratory Care Products (2014)
200 Pages | 67 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
In the United States (U.S.), more than 35 million people suffer from some form of respiratory disorder and 1 in 6 deaths are caused by chronic lung disease. According to the American Lung Association, the annual economic burden of lung disease in the U.S. is estimated at $154 billion, consisting of $95 billion in direct healthcare costs and $59 billion in indirect costs including lost work days. This dynamic new report from Medtech Insight includes analyses of products, current/forecast...[Read More]




U.S. Markets for Interventional Technologies for the Management of Peripheral Vascular Disorders (2014)
273 Pages | 62 Exhibits | 2014 Analysis | Forecasts Through 2017 | Relavancy 1
Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. The most commonly diagnosed form of PVD is plaque-related peripheral artery disease; among the other types of PVD are chronic venous insufficiency, deep vein thrombosis, and pulmonary embolism. In 2012, approximately 3.8 million interventional procedures for the diagnosis and treatment ...[Read More]




U.S. Markets for Neurosurgical and Neurointerventional Products (2014)
116 Pages | 36 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
This dynamic, new report from Medtech Insight includes analyses of selected products, current/forecast markets, surgical procedure volumes, competitors, market share by supplier, and opportunities in the U.S. Neurosurgical and Neurointerventional Products Market. Specifically, this report covers neurosurgical, neurointerventional and image-guided surgical navigation and brain radiotherapy systems used for the treatment of several acute and chronic disorders such as benign and malignant neopla...[Read More]




U.S. Markets for Specialty Endoscopic Surgery Products (2014)
173 Pages | 59 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Over the past several decades, a revolutionary transition has occurred among many surgical procedures that has taken them from an invasive open approach to minimally invasive/endoscopic methods due to advances in medical technology and surgical techniques. The adoption of endoscopy for many procedures has greatly benefited patients, as it reduces pain, recovery time, and scarring as well as hospital costs. The emergence of small-incision and incisionless procedures has resulted in the avail...[Read More]




U.S. Cancer Statistics Update 2014 (2014)
76 Pages | 18 Exhibits | 2014 Analysis | Forecasts Through | Relavancy 1
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that in 2014 nearly 1.7 million people in the country will be diagnosed with cancer and that approximately 585,720 will die from the disease in the same year. This new report from Medtech Insight includes statistics for new cancer cases, prevalence, and deaths due to the disease in 2014. Covered topics in this report include an overview of cancer in the U.S. including discus...[Read More]




European Markets for Spinal Motion-Preserving Devices (2014)
171 Pages | 43 Exhibits | 2014 Analysis | Forecasts Through 2017 | Relavancy 1
An estimated 34 million people in the 5 major European Union markets (France, Germany, Italy, Spain, and the United Kingdom) and the Benelux and Nordic regions suffer from chronic back pain, and the incidence is expected to increase over the next several years, largely due to an expanding elderly population and the growing incidence of degenerative disc disease. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportuni...[Read More]




U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening Products (2014)
261 Pages | 38 Exhibits | 2014 Analysis | Forecasts Through 2017 | Relavancy 1
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that nearly 1.7 million people in the country will be diagnosed with cancer in 2014, and that approximately 585,720 will die from the disease. In the fight against cancer, diagnostic ultrasound imaging, minimally invasive biopsy, and tissue screening are among the methods that allow physicians to detect malignancies at their earliest and most treatable stages. In 2012, approximate...[Read More]




International Markets for Vascular Access Site Closure Devices (2014)
179 Pages | 58 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have coronary and peripheral vascular disease is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in...[Read More]




U.S. Surgical Procedure Volumes (2014)
410 Pages | 95 Exhibits | 2014 Analysis | Forecasts Through 2019 | Relavancy 1
The number of laparoscopic/percutaneous surgical procedures performed in the United States (U.S.) has been gradually expanding over the years, reflecting the steady migration of patients from acute care settings and open surgery. By the end of 2010, outpatient procedures accounted for more than 50% of all surgeries performed in the U.S., compared with an estimated 30% in 2000. This trend is expected to continue over the forecast period covered by this report, though at a somewhat slower pac...[Read More]




Global Markets for Assisted Breathing, Airway Management, and Ventilation in 2014 (2014)
137 Pages | 80 Exhibits | 2014 Analysis | Forecasts Through 2019 | Relavancy 1
Ventilators and airway management products generated $4.8 billion in global revenues during 2013. As discussed extensively in LSI\'s new report, the global market for these products will be affected by key regional differences. In the U.S., where respiratory caseloads are expected to rise, greater preference will be given to systems that enable use for patients at all levels of acuity as well as those that facilitate the transition from costly intensive care settings. The European market will...[Read More]




U.S. Disease Incidence and Prevalence (2014)
380 Pages | 122 Exhibits | 2014 Analysis | Forecasts Through | Relavancy 1
This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013. Categories covered by this report include: Blood disorders (anemia and hemophilia); Cancer (breast, colon/rectum, lung, nervous system, ovaries, pancreas, prostate, and skin); Cardiovascular diseases/disorders (atherosclerosis, heart failure, high blo...[Read More]




Global Markets for Neonatal/Perinatal Monitoring and Treatment Products in 2014: Infant Warmers and Incubators (2014)
84 Pages | 37 Exhibits | 2014 Analysis | Forecasts Through 2019 | Relavancy 1
Infant warmers, incubators, and hybrid systems generated $486 million in global revenues during 2013. The market for these devices, which is analyzed in LSI\'s new report, will continue to be shaped by regional and local trends in annual births and the delivery of neonatal care. As such, it will differ strikingly between developed and emerging markets, especially in countries where many births continue to take place outside of healthcare institutions; furthermore, limited purchasing resources...[Read More]




2014 Global Opportunities in Medical Devices & Diagnostics (2014)
550 Pages | 154 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
The global medical devices and diagnostics (MD&D) market made further albeit modest progress in 2013-growing 2.0% to $365 billion-despite continued capital constraints and global economic challenges. Europe saw a modest rebound, whereas growth slowed considerably in the Asia-Pacific region as those nations regrouped. Acquisitions, many of which further consolidated the industry, continued as companies sought to increase sales and expand their penetration of focal and emerging segmen...[Read More]




U.S. Markets for Interventional Cardiology Products (2014)
270 Pages | 68 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have heart conditions is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in the U.S. suffer from co...[Read More]




U.S. Markets for Sports Medicine Products (2014)
176 Pages | 52 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Each year in the U.S., approximately 30 million children and teens participate in organized sports, and more than 200 million adults participate in non-work-related sports or recreational activities. Although these activities are generally beneficial to one\'s health, they do involve the risk of injury and associated healthcare costs. Each year, nearly 5 million people in the U.S. receive medical treatment for sports injuries including sprains/strains, dislocations/fractures, knee injuries,...[Read More]




France, Disease Incidence and Prevalence (2014)
236 Pages | 22 Exhibits | 2014 Analysis | Forecasts Through | Relavancy 1
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/disorders in France. Incidence and prevalence figures are for the year 2012, the most recent year for which data are available. This report is th...[Read More]




U.S. Markets for Diagnostic Oncology-Related Magnetic Resonance and Nuclear/Molecular Medicine Imaging Systems (2014)
180 Pages | 37 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
It is estimated that nearly 1.7 million people in the United States (U.S.) will be diagnosed with cancer in 2014, and that approximately 585,720 will die from the disease. Despite advancements in oncology (the branch of medicine that deals with cancer), the disease remains the second-leading cause of death in the country after heart disease. Today, a constellation of methods are used in the fight against cancer, including diagnostic imaging modalities such as magnetic resonance imaging (MRI...[Read More]




U.S. Markets for Invasive and Noninvasive Diagnostic Cardiology Products (2014)
264 Pages | 66 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
In the next decade, the number of people living in the United States (U.S.) with diseases/disorders of the heart and vascular system is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic conditions such as cardiovascular disease (CVD), diabetes, and obesity, which are exacerbated by unhealthful behaviors such as physical inactivity and tobacco smoking. Diagnostic interventional cardiology procedur...[Read More]




Women's Health: U.S. Markets for Female Urinary Incontinence Therapies (2014)
191 Pages | 52 Exhibits | 2014 Analysis | Forecasts Through 2017 | Relavancy 1
Incontinence may be defined as the involuntary loss of bladder or bowel control. In the United States (U.S.), urinary incontinence (UI) is highly prevalent. According to the National Association for Continence (NAFC), the condition affects more than 200 million people worldwide, with a conservative estimate of 25 million adults in the U.S. experiencing chronic or transient UI. The NAFC estimates that 75% to 80% of the UI population comprises women, with 9 million to 13 million suffering se...[Read More]




Global Markets for Wound Closure Devices in 2014: Sutures, Stapling Products, Hernia Meshes, and Negative Pressure Wound Therapy (2014)
114 Pages | 54 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Sales of sutures, stapling products, hernia meshes, and negative pressure wound therapy (NPWT) reached $9.7 billion in 2013. The global market for these wound closure and management devices, as analyzed in LSI\'s new report, is expected to see important changes through 2018, influenced by critical regional trends in surgical caseloads, purchasing resources, and the state of development with respect to outpatient and post-acute care. Competitive forces and strained financial resources among ho...[Read More]




U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (2014)
192 Pages | 43 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Pain is the single most common reason patients seek medical care, accounting for approximately half of all physician office visits in the United States (U.S.); some studies suggest that more than one-third of people in the U.S. suffer from a chronic pain condition at some point in their lives. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for pain management products. Product areas cov...[Read More]




U.S. Markets for General & Pelvic Endoscopic Surgery Products (2014)
305 Pages | 123 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
The rapid expansion of general laparoscopic surgery in the U.S. has been driven by patient demand for less invasive procedures as well as by the introduction of innovative endoscopic devices that have allowed many surgeons to become proficient in laparoscopic techniques. The laparoscope has been the most significant device affecting these changes, enabling procedures that are less invasive, low in cost, and require less time compared with open surgery. Surgical advances enabling small-inci...[Read More]




Global Markets for Neonatal/Perinatal Monitoring and Treatment Products in 2014: Infant Ventilation, Jaundice Management, and Neonatal and Perinatal Monitoring Technologies, 2014 (2014)
133 Pages | 67 Exhibits | 2014 Analysis | Forecasts Through 2019 | Relavancy 1
Global revenues from infant ventilators, jaundice management products, and neonatal and perinatal monitoring technologies reached $706 million in 2013. Explored in LSI\'s report, the market for these technologies will develop as a result of the global forces that are affecting the status of neonatal care, which include powerful regional and demographic trends; the transformation of institutional healthcare in emerging markets; trends in information technology and connectivity; and marketing a...[Read More]




Global Opportunities in Obesity Management Technologies (2013)
238 Pages | 110 Exhibits | 2013 Analysis | Forecasts Through 2018 | Relavancy 1
An estimated 1.3 billion people--representing nearly 30% of the global adult population--are overweight or obese, and the share is more than twice that in the U.S., Mexico, and selected nations of Europe and Middle East. Including its contribution to diabetes and cardiovascular disease, this epidemic is placing heavy demands on nations\' health delivery systems and shining a bright light on the unmet need for new approaches and products that can manage and reverse this trend. Diet, exercise ...[Read More]




Global Markets for Peripheral Vascular Stent Products (2015)
82 Pages | 46 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The global market for peripheral vascular stents, which was valued at $1.1 billion in 2013, has entered into a dynamic phase which will be characterized by the rising prevalence of peripheral artery disease (PAD), growing availability in key regional markets, and the adoption of potentially competitive products, such as drug-coated balloons (DCBs). In the U.S., where DCBs became commercially available in October 2014, the use of stents will continue to be driven by the availability of product...[Read More]




Global Markets for Vascular Closure Devices (2015)
105 Pages | 53 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The global market for vascular closure devices (VCDs), which are often used following arterial puncture for cardiac catheterizations and other procedures, was valued at $706 million in 2013. As analyzed in a new report by Life Science Intelligence, the use of these devices, which include implantables as well as external compression products, will be strongly influenced by regional and global trends toward the implementation of cost-effective care as well as the rising use of transradial acces...[Read More]




U.S. Ophthalmic Surgical Systems Market (2014)
84 Pages | 13 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
In the United States (U.S.), serious ophthalmic disease affects more than 35 million. This number is expected to significantly increase due to the aging of the population and disorders such as diabetes that may result in progressive vision loss. Alarmingly, the number of patients with cataracts is expected to increase significantly over the next decade, contributing a substantial increase in the number of cataract surgeries. The development of new, minimally invasive energy-based (laser/...[Read More]




Contact Us

Need help finding medtech research? Let us help you!